LENSAR, Inc. (LNSR) Revenue Growth
LENSAR, Inc. (LNSR) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2021-12-31 | 30.62% |
| 2022-12-31 | 2.61% |
| 2023-12-31 | 19.25% |
| 2024-12-31 | 26.87% |
| 2025-12-31 | 9.24% |
How LNSR compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| EOLS | Evolus Inc. | 11.61% |
| EW | Edwards Lifesciences Corporation | 11.55% |
| RDNT | RadNet Inc. | 11.51% |
| NEO | NeoGenomics Inc. | 10.11% |
| VRTX | Vertex Pharmaceuticals Incorporated | 8.90% |
These are five companies in the same sector as LNSR with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get LENSAR, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("LNSR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | LNSR | $8.58 | +4.00% | 0.11M |
| 3 | ||||
| 4 | ||||
| 5 |